Is it necessary to use targeted drugs for nasopharyngeal carcinoma?

Is it necessary to use targeted drugs for nasopharyngeal carcinoma?

1. Targeted treatment for nasopharyngeal carcinoma is relatively good. Targeted drugs for nasopharyngeal carcinoma include cetuximab, which has been approved, and nimotuzumab, which has been approved domestically. However, these are targeted proteins, or protein macromolecule drugs, which are combined with chemotherapy and radiotherapy. Currently, nasopharyngeal carcinoma is better treated with a combination of radiotherapy, chemotherapy and targeted drugs.

2. Early stage nasopharyngeal carcinoma is generally treated with simple radiotherapy, while middle and late stage require comprehensive radiotherapy and chemotherapy. Late stage patients who cannot tolerate chemotherapy can be treated with targeted therapy. Immunotherapy can also be used if the effect is poor. The treatment of nasopharyngeal carcinoma is mainly radiotherapy as the first choice, and some patients also need auxiliary chemotherapy.

Did the tumor disappear after radiotherapy for nasopharyngeal carcinoma?

Nasopharyngeal cancer is a malignant tumor of the ear, nose and throat that can cause symptoms such as hearing loss, tinnitus, and runny nose. The disease is also highly hereditary. The best treatment for pharyngeal cancer is radiotherapy and chemotherapy, which can control the spread of cancer cells and increase the patient's life expectancy. Timely treatment of pharyngeal cancer has a good prognosis. Conventional treatments for nasopharyngeal cancer include radiotherapy and chemotherapy, and molecular targeted drug therapy.

The most commonly used standard treatment is concurrent radiotherapy and chemotherapy, plus molecular targeted drug therapy. Many patients with nasopharyngeal cancer can get good results after radiotherapy. After radiotherapy, nasopharyngeal cancer tumors generally shrink.